Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Boston Children’s Hospital
Children's Hospital Medical Center, Cincinnati
University of California, Los Angeles
Information provided by (Responsible Party):
Boston Children’s Hospital Identifier:
First received: May 21, 2010
Last updated: July 23, 2014
Last verified: July 2014